Philogen SpA
MIL:PHIL

Watchlist Manager
Philogen SpA Logo
Philogen SpA
MIL:PHIL
Watchlist
Price: 19.2 EUR -1.54% Market Closed
Market Cap: 561.4m EUR
Have any thoughts about
Philogen SpA?
Write Note

Philogen SpA
Investor Relations

Philogen SpA engages engineering and clinical development of lead products capable of targeting angiogenesis. The company is headquartered in Sovicille, Siena and currently employs 135 full-time employees. The company went IPO on 2021-03-03. The firm develops products and technologies for the diagnosis and therapy of serious human diseases. The company has three anti-cancer antibody derivatives, produced with an in-house industrial process, into Phase I/II clinical studies. The majority of its technologies and products are based on high-affinity human monoclonal antibody fragments. Philogen SpA developed a patented technology, Iterative Colony Filter Screening, for the isolation of monoclonal antibodies, which requires neither immunization nor phage display. The firm's subsidiaries are Philotec, Philomed and Philochem. Philogen SpA is headquartered in Siena, Italy.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Duccio Neri
Co-Founder & Executive Chairman
No Bio Available
Prof. Dario Neri Ph.D.
Co-Founder, CEO , MD, CSO, President of the Scientific Advisory Board & Director
No Bio Available
Dr. Giovanni Neri
Co-Founder, Head of IP & Licensing and Executive Director
No Bio Available
Ms. Laura Baldi
Chief Financial Officer
No Bio Available
Dr. Alfredo Covelli M.D.
Chief Medical Officer
No Bio Available
Dr. Katia Lorizzo
Deputy CMO & Head of Clinical Operations
No Bio Available

Contacts

Address
SIENA
Sovicille
Via Bellaria, 35
Contacts
+39057717816
www.philogen.com
sparklesyt

See Also

Summary
PHIL intrinsic value, competitors valuation, and company profile.
DCF Valuation
PHIL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PHIL stock valuation using valuation multiples.
Wall Street Estimates
PHIL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PHIL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 213,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.